Cocrystals of Baicalein with Higher Solubility and Enhanced Bioavailability

Baicalein (Bai) is one of the most important bioactive flavonoids isolated from the well-known traditional Chinese medicine called “Huang Qin”. Though it has broad therapeutic capability, the bioavailability is limited due to its poor solubility. In this study, we aimed to modulate its solubility through cocrystallization. Cocrystals of Bai with isoniazide (Inia), isonicotinamide (Inam), caffeine (Caf), and theophylline (Tph) were obtained. And different cocrystallization methods lead to different cocrystal phases for Inam and Tph. These cocrystals were characterized using powder X-ray diffraction, thermogravimetric analysis, differential scanning calorimetry, dynamic vapor sorption, and Fourier transform infrared spectroscopy. Among all the cocrystals studied, BaiCaf is found to be superior in powder dissolution and pharmacokinetic behavior. Area under the curve values of BaiCaf is improved by a factor of 4.1, and the bioavailability of baicalein is thus expected to be accordingly increased. Given that C...

[1]  J. Xing,et al.  Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract , 2005, The Journal of pharmacy and pharmacology.

[2]  Haeyong Lee,et al.  Beta-Catenin mediates the anti-adipogenic effect of baicalin. , 2010, Biochemical and biophysical research communications.

[3]  Zhonggui He,et al.  Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin. , 2006, International journal of pharmaceutics.

[4]  Jianhui Liu,et al.  Baicalin prevents the production of hydrogen peroxide and oxidative stress induced by Aβ aggregation in SH-SY5Y cells , 2011, Neuroscience Letters.

[5]  A. Maguire,et al.  Cocrystallization of Nutraceuticals , 2015 .

[6]  Jun Peng,et al.  Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway. , 2014, Molecular medicine reports.

[7]  Limin Shi,et al.  Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability. , 2014, Journal of pharmaceutical sciences.

[8]  M. Sowa,et al.  Improving solubility of fisetin by cocrystallization , 2014 .

[9]  Abu T M Serajuddin,et al.  Trends in solubility of polymorphs. , 2005, Journal of pharmaceutical sciences.

[10]  T. Lu,et al.  Improving the Solubility and Bioavailability of Apixaban via Apixaban–Oxalic Acid Cocrystal , 2016 .

[11]  Gargi Mukherjee,et al.  Polymorphs, Salts, and Cocrystals: What’s in a Name? , 2012 .

[12]  P. Park,et al.  Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells , 2014, The FEBS journal.

[13]  Miranda L. Cheney,et al.  Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation. , 2012, Molecular pharmaceutics.

[14]  M. Sowa,et al.  A 1:1 cocrystal of baicalein with nicotinamide. , 2012, Acta crystallographica. Section C, Crystal structure communications.

[15]  T. Lu,et al.  Solubility and Dissolution Rate Enhancement of Triamterene by a Cocrystallization Method , 2015 .

[16]  T. Hong,et al.  Evaluation of the Anti-Inflammatory Effect of Baicalein on Dextran Sulfate Sodium-Induced Colitis in Mice , 2002, Planta medica.

[17]  Scott L. Childs,et al.  Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability. , 2013, Molecular pharmaceutics.

[18]  Q. Wang,et al.  Zinc coupling potentiates anti-HIV-1 activity of baicalin. , 2004, Biochemical and biophysical research communications.

[19]  H. Tong,et al.  Comparison of Spray Freeze Drying and the Solvent Evaporation Method for Preparing Solid Dispersions of Baicalein with Pluronic F68 to Improve Dissolution and Oral Bioavailability , 2011, AAPS PharmSciTech.

[20]  Ashwini Nangia,et al.  Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals , 2011 .

[21]  H. Hou,et al.  Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model , 2013, Journal of neuroscience research.

[22]  C. Xue,et al.  Ear Acupressure for Smoking Cessation: A Randomised Controlled Trial , 2013, Evidence-based complementary and alternative medicine : eCAM.

[23]  G. Desiraju,et al.  Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt. , 2013, Molecular pharmaceutics.

[24]  S. Hsiu,et al.  Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats , 2003, The Journal of pharmacy and pharmacology.

[25]  Hou Xiaolong,et al.  Enhancing Bioavailability of Dihydromyricetin through Inhibiting Precipitation of Soluble Cocrystals by a Crystallization Inhibitor , 2016 .

[26]  Jian-Dong Huang,et al.  Baicalein Inhibits Formation of α‐Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation , 2011, Chembiochem : a European journal of chemical biology.

[27]  Y. Kimura,et al.  Studies on Scutellariae Radix , 1981 .

[28]  M. Sowa,et al.  Cocrystals of fisetin, luteolin and genistein with pyridinecarboxamide coformers: crystal structures, analysis of intermolecular interactions, spectral and thermal characterization , 2013 .

[29]  Jian-rong Wang,et al.  Insight into the Phase Transformation among Various Solid Forms of Baicalein , 2015 .

[30]  P. K. Mediratta,et al.  Substitute of Animals in Drug Research: An Approach Towards Fulfillment of 4R's , 2011, Indian journal of pharmaceutical sciences.

[31]  A. Nangia,et al.  Tracing the Architecture of Caffeic Acid Phenethyl Ester Cocrystals: Studies on Crystal Structure, Solubility, and Bioavailability Implications , 2016 .

[32]  M. Li‐Weber.  New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. , 2009, Cancer treatment reviews.

[33]  Michael J Zaworotko,et al.  Cocrystals of quercetin with improved solubility and oral bioavailability. , 2011, Molecular pharmaceutics.